{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:29:31Z","timestamp":1772116171136,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"am","delay-in-days":670,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2019-06749"],"award-info":[{"award-number":["RGPIN-2019-06749"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jinorgbio.2023.112433","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:50:19Z","timestamp":1700625019000},"page":"112433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation"],"prefix":"10.1016","volume":"251","author":[{"given":"Kalvin","family":"Kwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Castro-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Martelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Orvain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Mellitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gaiddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Storr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5701","key":"10.1016\/j.jinorgbio.2023.112433_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/278261a0","article-title":"T antigen is bound to a host protein in SV40-transformed cells","volume":"278","author":"Lane","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The P53 pathway: origins, inactivation in Cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cellsig.2017.02.005","article-title":"Reverting P53 activation after recovery of cellular stress to resume with cell cycle progression","volume":"33","author":"Lazo","year":"2017","journal-title":"Cell. Signal."},{"issue":"6381","key":"10.1016\/j.jinorgbio.2023.112433_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"P53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jinorgbio.2023.112433_bb0025","doi-asserted-by":"crossref","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"P53 research: the past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.jinorgbio.2023.112433_bb0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human P53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.jinorgbio.2023.112433_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.jinorgbio.2023.112433_bb0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant P53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why are there hotspot mutations in the TP53 gene in human cancers?","volume":"25","author":"Baugh","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0055","first-page":"26","article-title":"Mutant P53: one name, many proteins","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61487","article-title":"Zinc shapes the folding landscape of P53 and establishes a pathway for reactivating structurally diverse Cancer mutants","volume":"9","author":"Blanden","year":"2020","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.jinorgbio.2023.112433_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jmb.2011.03.047","article-title":"Interaction of the P53 DNA-binding domain with its N-terminal extension modulates the stability of the P53 tetramer","volume":"409","author":"Natan","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102230","article-title":"Inhibition of P53 protein aggregation as a Cancer treatment strategy","volume":"72","author":"Kwan","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1389450114666140106101412","article-title":"Targeting tumor suppressor P53 for Cancer therapy: strategies, challenges and opportunities","volume":"15","author":"Bo","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0080","article-title":"Targeting mutant P53 for efficient Cancer therapy","volume":"89\u2013102","author":"Bykov","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.jinorgbio.2023.112433_bb0085","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm0996-985","article-title":"Retrovirus\u2013mediated wild\u2013type P53 gene transfer to tumors of patients with lung cancer","volume":"2","author":"Roth","year":"1996","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cgt.2008.69","article-title":"Recent advances in P53 research: an interdisciplinary perspective","volume":"16","author":"Olivier","year":"2009","journal-title":"Cancer Gene Ther."},{"issue":"18","key":"10.1016\/j.jinorgbio.2023.112433_bb0095","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41388-018-0652-y","article-title":"Cancer therapeutic targeting using mutant\u2013P53-specific siRNAs","volume":"38","author":"Ubby","year":"2019","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.jinorgbio.2023.112433_bb0100","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1039\/D0CS00163E","article-title":"A balancing act: using small molecules for therapeutic intervention of the P53 pathway in Cancer","volume":"49","author":"Miller","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.jinorgbio.2023.112433_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/biom10040635","article-title":"Recent synthetic approaches towards small molecule reactivators of P53","volume":"10","author":"Silva","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.jinorgbio.2023.112433_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/biom10020303","article-title":"Follow the mutations: toward class-specific, small-molecule reactivation of P53","volume":"10","author":"Loh","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.jinorgbio.2023.112433_bb0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10495-014-0990-3","article-title":"Small molecule compounds targeting the P53 pathway: are we finally making Progress?","volume":"19","author":"Yu","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00775-022-01939-2","article-title":"A role for bioinorganic chemistry in the reactivation of mutant P53 in Cancer","volume":"27","author":"Miller","year":"2022","journal-title":"J. Biol. Inorg. Chem."},{"issue":"Supplement C","key":"10.1016\/j.jinorgbio.2023.112433_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbpa.2016.12.011","article-title":"Developing drugs targeting transition metal homeostasis","volume":"37","author":"Weekley","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"10","key":"10.1016\/j.jinorgbio.2023.112433_bb0130","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1021\/acs.jmedchem.6b00238","article-title":"Zinc(II)\u2013Thiosemicarbazone complexes are localized to the lysosomal compartment where they Transmetallate with copper ions to induce cytotoxicity","volume":"59","author":"Stacy","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2023.112433_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166164","article-title":"Intracellular Iron chelation modulates the macrophage Iron phenotype with consequences on tumor progression","volume":"11","author":"Mertens","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinorgbio.2023.112433_bb0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C6MT00105J","article-title":"Copper and conquer: copper complexes of Di-2-Pyridylketone Thiosemicarbazones as novel anti-Cancer therapeutics","volume":"8","author":"Park","year":"2016","journal-title":"Metallomics"},{"issue":"11","key":"10.1016\/j.jinorgbio.2023.112433_bb0145","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1021\/acs.inorgchem.7b00710","article-title":"Bis(Thiosemicarbazone) Complexes of cobalt(III). Synthesis, characterization, and anticancer potential","volume":"56","author":"King","year":"2017","journal-title":"Inorg. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2023.112433_bb0150","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acs.bioconjchem.6b00332","article-title":"Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators","volume":"27","author":"Akam","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102363","article-title":"The role of metals in the next generation of anticancer therapeutics","volume":"76","author":"Wilson","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"67","key":"10.1016\/j.jinorgbio.2023.112433_bb0160","doi-asserted-by":"crossref","first-page":"17734","DOI":"10.1002\/chem.201802677","article-title":"Multifunctional compounds for activation of the P53-Y220C mutant in Cancer","volume":"24","author":"Miller","year":"2018","journal-title":"Chem. Eur. J."},{"issue":"11","key":"10.1016\/j.jinorgbio.2023.112433_bb0165","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.drudis.2015.07.006","article-title":"Reactivating mutant P53 using small molecules as zinc Metallochaperones: awakening a sleeping Giant in Cancer","volume":"20","author":"Blanden","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.jinorgbio.2023.112433_bb0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1124\/mol.114.097550","article-title":"Synthetic Metallochaperone ZMC1 rescues mutant P53 conformation by transporting zinc into cells as an Ionophore","volume":"87","author":"Blanden","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.jinorgbio.2023.112433_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/mol.116.107409","article-title":"Thiosemicarbazones functioning as zinc Metallochaperones to reactivate mutant P53","volume":"91","author":"Yu","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0180","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.18632\/oncotarget.2432","article-title":"Small molecule restoration of wildtype structure and function of mutant P53 using a novel zinc-Metallochaperone based mechanism","volume":"5","author":"Yu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/onci.26198","article-title":"Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in Chemoresistant P53-functionally deficient cells","volume":"2","author":"Cirone","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0190","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2015.3125","article-title":"Zn(II)-Curc targets P53 in thyroid Cancer cells","volume":"47","author":"Garufi","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.217","article-title":"Degradation of mutant p53H175 protein by Zn(II) through autophagy","volume":"5","author":"Garufi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.jinorgbio.2023.112433_bb0200","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acs.jmedchem.0c01360","article-title":"Benzothiazolyl and Benzoxazolyl Hydrazones function as zinc Metallochaperones to reactivate mutant P53","volume":"64","author":"Gilleran","year":"2021","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.jinorgbio.2023.112433_bb0205","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-18-0822","article-title":"Zinc Metallochaperones reactivate mutant P53 using an ON\/OFF switch mechanism: a new paradigm in Cancer therapeutics","volume":"24","author":"Yu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"6586","key":"10.1016\/j.jinorgbio.2023.112433_bb0210","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting Lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0215","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-18-1080","article-title":"Combinatorial therapy of zinc Metallochaperones with mutant P53 reactivation and diminished copper binding","author":"Zaman","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.jinorgbio.2023.112433_bb0220","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1021\/ja301056a","article-title":"Halogen-enriched fragment libraries as leads for drug rescue of mutant P53","volume":"134","author":"Wilcken","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0225","series-title":"Critical Stability Constants","volume":"vol. 5","author":"Martell","year":"1982"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112164","article-title":"Multifunctional Metallochaperone modifications for targeting subsite cavities in mutant P53-Y220C","volume":"242","author":"Miller","year":"2023","journal-title":"J. Inorg. Biochem."},{"issue":"18","key":"10.1016\/j.jinorgbio.2023.112433_bb0235","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1021\/jm0201520","article-title":"Discovery of Aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities","volume":"45","author":"Kim","year":"2002","journal-title":"J. Med. Chem."},{"issue":"46","key":"10.1016\/j.jinorgbio.2023.112433_bb0240","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.tetlet.2007.09.074","article-title":"A simple method for the alkaline hydrolysis of esters","volume":"48","author":"Theodorou","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-8545(98)00260-4","article-title":"Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species","volume":"184","author":"Alderighi","year":"1999","journal-title":"Coord. Chem. Rev."},{"issue":"2","key":"10.1016\/j.jinorgbio.2023.112433_bb0250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/abio.1995.9984","article-title":"Nuclear magnetic resonance as a tool for determining protonation constants of natural Polyprotic bases in solution","volume":"231","author":"Frassineti","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1039\/a908384g","article-title":"Acid\u2013base and metal ion-binding properties of diaminopropyl d-glucopyranoside and diaminopropyl d-mannopyranoside compounds in aqueous solution","volume":"8","author":"Song","year":"2000","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0260","article-title":"Extent of the acidification by N7-coordinated Cis-Diammine-platinum(II) on the acidic sites of guanine derivatives","volume":"3","author":"Song","year":"1900","journal-title":"Metal-Based Drugs"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0265","series-title":"PKa Prediction for Organic Acids and Bases","author":"Perrin","year":"1981"},{"issue":"23","key":"10.1016\/j.jinorgbio.2023.112433_bb0270","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1021\/ja068965r","article-title":"Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer\u2019s therapy","volume":"129","author":"Storr","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jinorgbio.2023.112433_bb0275","first-page":"351","article-title":"1H NMR study of N-(o-Hydroxybenzyl)Iminodiacetic acid and its complexes with lanthanum and Luetetium","volume":"38","author":"Novomesky","year":"1984","journal-title":"Chem. Zvesti"},{"issue":"10","key":"10.1016\/j.jinorgbio.2023.112433_bb0280","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1021\/acs.inorgchem.6b00359","article-title":"CF3 derivatives of the anticancer Ru(III) complexes KP1019, NKP-1339, and their imidazole and pyridine analogues show enhanced lipophilicity, albumin interactions, and cytotoxicity","volume":"55","author":"Chang Stephanie","year":"2016","journal-title":"Inorg. Chem."},{"issue":"24","key":"10.1016\/j.jinorgbio.2023.112433_bb0285","doi-asserted-by":"crossref","first-page":"16353","DOI":"10.1021\/acs.jmedchem.2c01174","article-title":"Potent ruthenium\u2013ferrocene bimetallic antitumor antiangiogenic agent that circumvents platinum resistance: from synthesis and mechanistic studies to in vivo evaluation in zebrafish","volume":"65","author":"M","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0290","series-title":"Metal Complexes in Aqueous Solutions","author":"Martell","year":"1996"},{"issue":"51","key":"10.1016\/j.jinorgbio.2023.112433_bb0295","doi-asserted-by":"crossref","first-page":"21990","DOI":"10.1073\/pnas.1006091107","article-title":"Design of Small Molecules That Target Metal-A\u03b2 Species and Regulate Metal-Induced A\u03b2 Aggregation and neurotoxicity","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"20","key":"10.1016\/j.jinorgbio.2023.112433_bb0300","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1021\/ja00514a037","article-title":"Coordination chemistry of microbial Iron transport compounds. 19. Stability constants and electrochemical behavior of ferric Enterobactin and model complexes","volume":"101","author":"Harris","year":"1979","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.jinorgbio.2023.112433_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040916","article-title":"Isoforms of the P53 family and gastric Cancer: a M\u00e9nage \u00e0 trois for an unfinished affair","volume":"13","author":"Blanchet","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.04.035","article-title":"Aminobenzothiazole derivatives stabilize the Thermolabile P53 Cancer mutant Y220C and show anticancer activity in P53-Y220C cell lines","volume":"152","author":"Baud","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0315","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1476-4598-8-103","article-title":"Elevated expression of P53 gain-of-function mutation R175H in endometrial Cancer cells can increase the invasive phenotypes by activation of the EGFR\/PI3K\/AKT pathway","volume":"8","author":"Dong","year":"2009","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910640109","article-title":"The mutational status of P53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents","volume":"64","author":"Nabeya","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.jinorgbio.2023.112433_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164088","article-title":"The function of the mutant P53-R175H in Cancer","volume":"13","author":"Chiang","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jinorgbio.2023.112433_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100050","article-title":"Protocol for quantifying zinc flux in cultured cells using fluorescent indicators","volume":"1","author":"Ali","year":"2020","journal-title":"STAR Protoc."},{"issue":"5","key":"10.1016\/j.jinorgbio.2023.112433_bb0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0143-4160(02)00053-2","article-title":"Measuring zinc in living cells.: a new generation of sensitive and selective fluorescent probes","volume":"31","author":"Gee","year":"2002","journal-title":"Cell Calcium"},{"issue":"17","key":"10.1016\/j.jinorgbio.2023.112433_bb0340","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1021\/ja4001272","article-title":"Controlled pH stability and adjustable cellular uptake of mixed-charge nanoparticles","volume":"135","author":"Pillai","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"45","key":"10.1016\/j.jinorgbio.2023.112433_bb0345","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1021\/bi800856t","article-title":"Mechanism of cellular uptake of a ruthenium Polypyridyl complex","volume":"47","author":"Puckett","year":"2008","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.jinorgbio.2023.112433_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200796","article-title":"Recent advances in metal complexes for antimicrobial photodynamic therapy","volume":"24","author":"Rees","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0355","unstructured":"Unpublished Cytotoxicity Data from Collaborators."},{"issue":"10","key":"10.1016\/j.jinorgbio.2023.112433_bb0360","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.jinorgbio.2023.112433_bb0365","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.jinorgbio.2023.112433_bb0370","first-page":"1","article-title":"Anti-Cancer efficacy and mechanisms of Usnic acid","volume":"7","author":"Kumar","year":"2019","journal-title":"Indian J. Pharm. Biol. Res."},{"issue":"6","key":"10.1016\/j.jinorgbio.2023.112433_bb0375","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40495-019-00202-8","article-title":"Usnic acid derivatives as cytotoxic agents against Cancer cells and the mechanisms of their activity","volume":"5","author":"Guzow-Krzemi\u0144ska","year":"2019","journal-title":"Curr. Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.jinorgbio.2023.112433_bb0380","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1096\/fj.02-0020fje","article-title":"Stressful death of T-ALL tumor cells following treatment with the antitumor agent Tetrocarcin-a","volume":"16","author":"Tinhofer","year":"2002","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.jinorgbio.2023.112433_bb0385","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1182\/blood-2002-08-2501","article-title":"Tetrocarcin-A\u2014induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2\u2014independent pathway","volume":"101","author":"Anether","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0390","doi-asserted-by":"crossref","first-page":"2969271","DOI":"10.1155\/2017\/2969271","article-title":"Unfolded protein response of the endoplasmic reticulum in tumor progression and immunogenicity","volume":"2017","author":"Yoo","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0395","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbamcr.2014.10.013","article-title":"Glaucarubinone inhibits colorectal Cancer growth by suppression of hypoxia-inducible factor 1\u03b1 and \u03b2-catenin via a p-21 activated kinase 1-dependent pathway","volume":"1853","author":"Huynh","year":"2015","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.jinorgbio.2023.112433_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041700","article-title":"Anti-Cancer effects of Glaucarubinone in the hepatocellular carcinoma cell line Huh7 via regulation of the epithelial-to-mesenchymal transition-associated transcription factor Twist1","volume":"22","author":"Seo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jinorgbio.2023.112433_bb0405","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ptr.5054","article-title":"Herbal therapeutics That block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity","volume":"28","author":"Maruta","year":"2014","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.jinorgbio.2023.112433_bb0410","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/humu.22556","article-title":"Analysis of TP53 mutation status in human Cancer cell lines: a reassessment","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0415","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-0716-2309-1_24","article-title":"A plate reader-based measurement of the cellular ROS production using Dihydroethidium and MitoSOX","volume":"2497","author":"Chung","year":"2022","journal-title":"Methods Mol. Biol. Clifton NJ"},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40170-018-0191-6","article-title":"P53-mediated adaptation to serine starvation is retained by a common tumour-derived mutant","volume":"6","author":"Humpton","year":"2018","journal-title":"Cancer Metab."},{"issue":"6","key":"10.1016\/j.jinorgbio.2023.112433_bb0425","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/acs.jmedchem.8b01996","article-title":"Novel Triapine derivative induces copper-dependent cell death in hematopoietic cancers","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.jinorgbio.2023.112433_bb0430","doi-asserted-by":"crossref","first-page":"14758","DOI":"10.1021\/jacs.2c05355","article-title":"Copper-catalyzed glutathione oxidation is accelerated by the anticancer Thiosemicarbazone Dp44mT and further boosted at lower pH","volume":"144","author":"Falcone","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.jinorgbio.2023.112433_bb0435","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxlet.2010.12.017","article-title":"The Iron-chelating drug Triapine causes pronounced mitochondrial thiol redox stress","volume":"201","author":"Myers","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"20","key":"10.1016\/j.jinorgbio.2023.112433_bb0440","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of Pyridine-2-Carboxaldehyde Thiose Micarbazone","volume":"35","author":"Liu","year":"1992","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jinorgbio.2023.112433_bb0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1006327418043","article-title":"A phase II trial of Homoharringtonine and Caracemide in the treatment of patients with advanced large bowel Cancer","volume":"17","author":"Witte","year":"1999","journal-title":"Investig. New Drugs"},{"issue":"18","key":"10.1016\/j.jinorgbio.2023.112433_bb0450","doi-asserted-by":"crossref","first-page":"12627","DOI":"10.1016\/S0021-9258(18)42323-X","article-title":"Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia Coli ribonucleotide reductase","volume":"267","author":"Larsen","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0455","series-title":"The hydrolysis of cations","author":"Baes","year":"1976"},{"issue":"21","key":"10.1016\/j.jinorgbio.2023.112433_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215255","article-title":"Molecular mechanisms of Mitotane action in adrenocortical Cancer based on in vitro studies","volume":"13","author":"Lo Iacono","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.jinorgbio.2023.112433_bb0465","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1159\/000484069","article-title":"Cantharidin inhibits the growth of triple-negative breast Cancer cells by suppressing autophagy and inducing apoptosis in vitro and in vivo","volume":"43","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0470","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-8546-2-8","article-title":"Molecular biology of Cantharidin in Cancer cells","volume":"2","author":"Rauh","year":"2007","journal-title":"Chin. Med."},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0475","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/recl.19881071209","volume":"107","author":"Kieboom","year":"1988","journal-title":"Recl. Trav. Chim. Pays-Bas"},{"key":"10.1016\/j.jinorgbio.2023.112433_bb0480","series-title":"Purification of Laboratory Chemicals","author":"Perrin","year":"1988"},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0485","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jinorgbio.2003.10.001","article-title":"A formula for correlating pKa values determined in D2O and H2O","volume":"98","author":"Kr\u0229\u017cel","year":"2004","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2023.112433_bb0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"12","key":"10.1016\/j.jinorgbio.2023.112433_bb0495","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/sj.cdd.4402216","article-title":"Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis","volume":"14","author":"Benosman","year":"2007","journal-title":"Cell Death Differ."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342300315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342300315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:12:01Z","timestamp":1758985921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016201342300315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":99,"alternative-id":["S016201342300315X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112433","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112433"}}